Literature DB >> 21513487

Micro-RNA in disease and gene therapy.

Kenneth Lundstrom1.   

Abstract

The key regular functions of microRNAs (miRNAs) were only discovered a few years ago, when it became evident that miRNAs play important roles in gene regulation. Today, more than 700 miRNAs have been identified from the human genome. Because of their regulatory functions in transcription, signal transduction, cell cycle regulation, proliferation, cell growth, apoptosis, cell metabolism and neurogenesis, malfunctioning miRNAs have been suggested to affect a number of diseases. Indeed, absence of miRNAs or their mutations has been associated with various types of cancers and other diseases such as neurodegenerative, autoimmune, cardiovascular, infectious, metabolic and oncologic diseases. This has been confirmed by genetic analysis of patient samples. The disease association has attracted potential diagnostic and therapeutic applications of miRNAs. A significant issue to achieve successful therapy is the delivery of miRNAs as problems of targeted and long-lasting presence of miRNA exist. Different approaches have included the modification of miRNAs and the use of viral delivery vectors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21513487     DOI: 10.2174/157016311795563857

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN: 1570-1638


  17 in total

1.  Suppression of endothelial nitric oxide synthase expression and endothelial cell proliferation by an intronic 27-ntmiRNA and it's a novel link to AP-1.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Nan Hu; Wei Chen; Hui Wang; Min Kang; Hesheng Ou
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 2.  miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.

Authors:  Ying Zheng; Zhen Wang; Zhiguang Zhou
Journal:  Cell Mol Immunol       Date:  2017-03-20       Impact factor: 11.530

Review 3.  Regulation of cancer metastasis by cell-free miRNAs.

Authors:  Maša Alečković; Yibin Kang
Journal:  Biochim Biophys Acta       Date:  2014-10-28

4.  Evaluation and optimization of chitosan derivatives-based gene delivery system via kidney epithelial cells.

Authors:  S Safari; M H Zarrintan; M Soleimani; F A Dorkoosh; H Akbari; B Larijani; M Rafiee Tehrani
Journal:  Adv Pharm Bull       Date:  2012-02-15

Review 5.  Novel molecular targets for atrial fibrillation therapy.

Authors:  Dobromir Dobrev; Leif Carlsson; Stanley Nattel
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

6.  Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.

Authors:  Amit K Maiti; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

7.  [Trichostatin A suppresses up-regulation of histone deacetylase 4 and reverses differential expressions of miRNAs in the spinal cord of rats with chronic constrictive injury].

Authors:  Bihan Ouyang; Zhaohui Tang; Xinran Hou; Dan Chen; Qulian Guo; Yingqi Weng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

8.  MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR.

Authors:  Xuemei Sun; Chunlai Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.

Authors:  Lilach Soreq; Nathan Salomonis; Michal Bronstein; David S Greenberg; Zvi Israel; Hagai Bergman; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-05-13       Impact factor: 5.639

10.  Evaluation of the plasma micro RNA expression levels in secondary hemophagocytic lymphohistiocytosis.

Authors:  Ali Bay; Enes Coskun; Serdar Oztuzcu; Sercan Ergun; Fatih Yilmaz; Elif Aktekin
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.